ReviewInfection and drug resistance2026
Antimicrobial Resistance in Somalia: Surveillance Gaps, Stewardship Barriers, and One Health Priorities.
Review in Infection and drug resistance, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Microbial etiology and antimicrobial resistance patterns in neonates admitted to a tertiary neonatal intensive care unit in Mogadishu, Somalia.Frontiers in pediatrics · 2026Article
- Operationalizing the WHO Blueprint for Fungal Disease and Antifungal Resistance in Fragile Health Systems: Insights from Somalia.Infection and drug resistance · 2026Article
- The Untapped Potential of One Health in Somalia: A Call for Cross-Sectoral Action Against Persistent Infectious Diseases.Risk management and healthcare policy · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This narrative review examines antimicrobial resistance (AMR) in Somalia, with emphasis on surveillance gaps, stewardship barriers, and One Health priorities. Peer-reviewed and selected grey literature published between 2010 and March 2026 was reviewed using major bibliographic databases and relevant policy sources. The available Somalia-specific evidence remains limited, heterogeneous, and concentrated mainly in facility-based studies from urban settings, particularly Mogadishu. Existing findings indicate concerning resistance patterns among major bacterial pathogens, while national surveillance systems, laboratory capacity, quality assurance, antimicrobial stewardship structures, and regulatory oversight remain underdeveloped. Evidence from animal health, food systems, and environmental sectors is also sparse, limiting operational implementation of a One Health response. Strengthening AMR control in Somalia requires phased investment in sentinel surveillance, microbiology and antimicrobial susceptibility testing, antimicrobial stewardship, pharmaceutical regulation, infection prevention and control, water, sanitation and hygiene, and multisectoral coordination. Addressing AMR in Somalia will depend on both AMR-specific interventions and broader health-system strengthening.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.